Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11714 | Durvalumab | 0 | Active Not Recruiting | 1 |
DB11771 | Tremelimumab | 0 | Active Not Recruiting | 1 |
DB08871 | Eribulin | 1 / 2 | Active Not Recruiting | 1 |
DB08871 | Eribulin | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB09035 | Nivolumab | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |
DB11836 | Sapanisertib | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 3 | Recruiting | 1 |
DB09037 | Pembrolizumab | 3 | Active Not Recruiting | 1 |
DB14851 | Relatlimab | 3 | Recruiting | 1 |